Corcept Therapeutics (CORT), Mid/Small Cap AI Study of the Week
Corcept Therapeutics Inc. is a pharmaceutical company focused on the development of drugs that modulate the effects of cortisol. Their key product, Korlym, has been on the market since 2012 for the treatment of Cushing's syndrome.